Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia

Antimicrob Agents Chemother. 2013 Jan;57(1):655-7. doi: 10.1128/AAC.01020-12. Epub 2012 Nov 12.

Abstract

A Stenotrophomonas maltophilia mutant that coordinately hyper-expresses three resistance nodulation division-type efflux pump genes, smeZ, smeJ, and smeK, has been identified. SmeZ is responsible for elevating aminoglycoside MICs; SmeJ and SmeK are jointly responsible for elevating tetracycline, minocycline, and ciprofloxacin MICs and conferring levofloxacin resistance. One clinical isolate with this same phenotype was identified from a sample of six, and the isolate also coordinately hyper-expresses smeZ and smeJK, confirming the clinical relevance of our findings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / biosynthesis*
  • Bacterial Proteins / genetics
  • Bacterial Toxins / biosynthesis*
  • Bacterial Toxins / genetics
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use
  • Gene Expression
  • Genes, MDR*
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Levofloxacin
  • Membrane Transport Proteins / biosynthesis*
  • Membrane Transport Proteins / genetics
  • Microbial Sensitivity Tests
  • Minocycline / pharmacology
  • Minocycline / therapeutic use
  • Ofloxacin / pharmacology
  • Ofloxacin / therapeutic use
  • Stenotrophomonas maltophilia / drug effects
  • Stenotrophomonas maltophilia / genetics*
  • Stenotrophomonas maltophilia / isolation & purification
  • Tetracycline / pharmacology
  • Tetracycline / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacterial Toxins
  • Membrane Transport Proteins
  • Ciprofloxacin
  • Levofloxacin
  • Ofloxacin
  • Tetracycline
  • Minocycline